Flt-4 (D-6) Antibody sc-28297 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemFlt-4 (D-6) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-28297
Antibody TypePrimary Antibodies
NCBI Gene AliasesCHTD7, FLT-4, FLT41, LMPH1A, LMPHM1, PCL, VEGFR-3, VEGFR3
Quantity200 µg/ml
CloneD-6
Reactivityhuman
ApplicationsWB, IP, IF, IHC(P), ELISA
Hostmouse
Conjugate/TagUnconjugated
FormatPurified
ClonalityMonoclonal
NCBI Full Gene Namefms related receptor tyrosine kinase 4
TargetFlt-4
IsotypeIgG2b

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling StudyCancers (Basel)December 30, 2025Svetlana S. Zykova, Tatyana Gessel, Aigul Galembikova, Evgenii S. Mozhaitsev, Sophia S. Borisevich, Nazim Igidov, Emiliya S. Egorova, Ekaterina Mikheeva, Natalia Khromova, Pavel Kopnin, et al.actin (A00730-200, Abcam, Cam-bridge, MA, USA); and HIF-1α (sc-10790), VEGF-1 (sc-271789), and VEGF-3 (sc-28297) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). HRP-conjugated secondary antibodies for Western blotting

(2) APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signalingNat CommunOctober 21, 2025Jun-Dae Kim, Surbhi Chaudhary, Weiqing Chen, Jonathan Astin, Philip S. Crosier, Pengchun Yu, John P. Cooke, Henry J. Pownall, Hugo J. Bellen, Nhat-Tu Le, et al.captured using protein GFP A/G agarose (Cat #SC-9996 AC, Santa Cruz) or IgG A/G agarose beads (Cat #SC-28297, Santa Cruz). Following extensive washing, the beads were boiled in SDS reducing sample buffer. The

(3) Exosomal circ_0026611 contributes to lymphangiogenesis by reducing PROX1 acetylation and ubiquitination in human lymphatic endothelial cells (HLECs)Cellular & molecular biology lettersFebruary 17, 2023Yao W, Jia X, Zhu L, Xu L, Zhang Q, Xia T, Wei L.Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-VEGFR3 (vascular endothelial growth factor receptor 3, sc-28297, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-LYVE-1 (lymphatic vessel endothelial hyaluronan

(4) MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3Frontiers in pharmacologyJanuary 1, 2021Yamamura A, Nayeem MJ, Muramatsu H, Nakamura K, Sato M.p-VEGFR-2 (Tyr996, #2474, Cell Signaling Technology), VEGFR-3 (#79-633, ProSci, Poway, CA, United States; sc-28297 and sc-321, Santa Cruz Biotechnology, Santa Cruz, TX, United States), p-Akt (Ser473, #9271, Cell Signaling Technology

(5) Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanomaMolecular oncologyJune 1, 2019Monteiro AC, Muenzner JK, Andrade F, Rius FE, Ostalecki C, Geppert CI, Agaimy A, Hartmann A, Fujita A, Schneider-Stock R, et al.

(6) Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathwayOncology reportsApril 1, 2019Ho JN, Byun SS, Lee SE, Youn JI, Lee S.VEGFR‑2 (cat. no. 2479) (Cell Signaling Technology, Inc., Beverly, MA, USA); and VEGFR‑3 (cat. no. sc‑28297) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) at 4˚C overnight. After incubation with horseradish

(7) Increased protein expression of VEGF-A, VEGF-B, VEGF-C and their receptors in the temporal neocortex of pharmacoresistant temporal lobe epilepsy patientsJournal of neuroimmunologyMarch 15, 2019Castañeda-Cabral JL, Beas-Zárate C, Rocha-Arrieta LL, Orozco-Suárez SA, Alonso-Vanegas M, Guevara-Guzmán R, Ureña-Guerrero ME.

(8) Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantationJournal of translational medicineMarch 3, 2014Zakaria N, Possemiers T, Dhubhghaill SN, Leysen I, Rozema J, Koppen C, Timmermans JP, Berneman Z, Tassignon MJ.endothelial growth factor receptors VEGF-R1 (Epitomics: 1303–1, 1/250) and VEGF R3/FLT (Santa Cruz: Sc-28297, 1/50) was also investigated (data not shown). Normal human corneal cross sections were routinely used

(9) Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantationActa OphthalmologicaAugust 1, 2013N ZAKARIA, C KOPPEN, MJ TASSIGNONendothelial growth factor receptors VEGF-R1 (Epitomics: 1303–1, 1/250) and VEGF R3/FLT (Santa Cruz: Sc-28297, 1/50) was also investigated (data not shown). Normal human corneal cross sections were routinely used

(10) Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cellsJournal of molecular medicine (Berlin, Germany)March 1, 2013Spinella F, Caprara V, Di Castro V, Rosanò L, Cianfrocca R, Natali PG, Bagnato A.

(11) Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancerJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerMarch 1, 2012Siegfried JM, Gubish CT, Rothstein ME, Henry C, Stabile LP.

(12) VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cellsJournal of cell scienceSeptember 15, 2009Sase H, Watabe T, Kawasaki K, Miyazono K, Miyazawa K.

(13) Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cellsJournal of cell scienceSeptember 15, 2009Pan MR, Chang TM, Chang HC, Su JL, Wang HW, Hung WC.

(14) The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cellsCancer cellMarch 1, 2006Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, et al.

Be the First to Write a Review!

Flt-4 (D-6) Antibody

Flt-4 (D-6) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (14)

Reviews

Flt-4 (D-6) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map